CAS: 1262238-11-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | INCB3344 REF: 54-BUP09092CAS: 1262238-11-8 | ≥98% | 615.00 €~2,182.00 € | Wed 30 Apr 25 |
 | INCB 3344 REF: 3D-FI104132CAS: 1262238-11-8 | Min. 95% | 4,662.00 €~5,328.00 € | Tue 10 Jun 25 |
 | INCB3344 REF: TM-TQ0103CAS: 1262238-11-8 | 98.00% - 98.2% | 70.00 €~868.00 € | Tue 15 Jul 25 |
Ref: 54-BUP09092
| 25mg | 615.00 € | ||
| 50mg | 895.00 € | ||
| 100mg | 1,175.00 € | ||
| 500mg | 2,182.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
INCB 3344
CAS:1262238-11-8
Chemokine receptor 2 (CCR2) antagonist
Formula:
C29H34F3N3O6
Purity:
Min. 95%
Molecular weight:
577.59 g/mol
Ref: 3D-FI104132
| 1g | 4,662.00 € | ||
| 5g | 5,328.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
INCB3344
CAS:1262238-11-8
INCB3344 is an effective, specific and orally bioavailable CCR2 antagonist with IC50 values of 9.5 …
Formula:
C29H34F3N3O6
Purity:
98.00% - 98.2%
Color and Shape:
Solid
Molecular weight:
577.59
Ref: TM-TQ0103
| 1mg | 70.00 € | ||
| 5mg | 153.00 € | ||
| 10mg | 243.00 € | ||
| 25mg | 411.00 € | ||
| 50mg | 610.00 € | ||
| 100mg | 868.00 € | ||
| 1mL*10mM (DMSO) | 188.00 € |
Estimated delivery in United States, on Tuesday 15 Jul 2025
